Poster zum Thema "Diagnostic and therapeutic nuclear medicine"

Zurück
  • PP02.14
  • Eposter presentation
Predicting treatment response in Hodgkin's lymphoma patients using decision tree algorithm and explainable AI methods
  • PP11.01
  • Eposter presentation
AlphaMet: A European project on metrology for emerging targeted alpha therapies
  • PP11.02
  • Eposter presentation
Deciphering the enigma of atypical forms of Alzheimer's disease by employing connectomics in the context of early and late-phase Amyloid PET and [18F]FDG PET Imaging
  • PP11.03
  • Eposter presentation
Large-cohort evaluation of normal organ uptake in 177Lu-PSMA therapy and relationship to total tumour burden on quantitative SPECT/CT using deep learning
  • PP11.04
  • Eposter presentation
CT organ dose estimation in whole-body PET/CT – Comparison of a patient-specific Monte Carlo and a computational phantom-based CT dosimetry tool
  • PP11.06
  • Eposter presentation
Impact of PET image reconstruction parameters on the recovered total activity for 90Y radioembolization
  • PP11.07
  • Eposter presentation
Assessment of 68Ga-PSMA receptor saturation after therapeutic infusion using a PBPK model
  • PP11.08
  • Eposter presentation
LU-177 PSMA therapy without hospitalisation: A feasibility study based on the use of dedicated toilet filter systems
  • PP11.09
  • Eposter presentation
Digital PET optimisation, process and pitfalls
  • PP11.10
  • Eposter presentation
Influence of OSEM reconstruction parameters and MC collimator modeling on 166Ho activity quantification in SPECT/CT imaging
  • PP11.11
  • Eposter presentation
A practical method for estimating residual activity in radioembolization with 90Y microspheres
  • PP11.12
  • Eposter presentation
Comparison of dosimetry software packages for planar image-based dosimetry in prostate cancer patients with 177Lu radioligand therapy
  • PP11.13
  • Eposter presentation
Validation of Monte-Carlo-based Iterative SPECT Reconstruction: Comparison against standard clinical reconstruction algorithms
  • PP11.14
  • Eposter presentation
Comparison of dose indicators in PET scans for different radiopharmaceuticals
  • PP14.04
  • Eposter presentation
High-Z organic scintillators for fast and flexible total body nuclear imaging diagnoses: The reSPECT project
  • PP16.15
  • Eposter presentation
A PSMA PET/MR regression model to reduce unnecessary biopsies
  • PP25.01
  • Eposter presentation
Automated 68Ga-PSMA-PET Total Metabolic Tumor Volume (TMTV) extraction for predicting PSA change in 177Lu-PSMA therapy
  • PP25.04
  • Eposter presentation
Non-linear mixed-effects modelling for kidneys time-integrated activity determination in [177Lu]Lu-PSMA-617 therapy
  • PP25.05
  • Eposter presentation
Non-linear mixed-effect modelling including covariate information in [177Lu]Lu-PSMA-617 therapy
  • PP25.06
  • Eposter presentation
Enhancing image quality in pediatric renal scintigraphy: A path towards dose reduction
  • PP25.07
  • Eposter presentation
SPECT/CT system for quantification of [123]I-Ioflupane: A phantom comparison study
  • PP25.08
  • Eposter presentation
Free breathing CT protocols for attenuation correction in data-driven gating PET/CT techniques
  • PP25.09
  • Eposter presentation
Patlak parameters for whole body PET – Analysis of reconstruction stability
  • PP25.10
  • Eposter presentation
A proposed method for estimation of disease burden in patients with multiple myeloma measured by [18F]FDG and [18F]fluciclovine
  • PP25.11
  • Eposter presentation
Impact of different algorithms and body mass index in SUV quantification of 18F PET/CT images from two vendors
  • PP25.12
  • Eposter presentation
Comparison of SUV quantification in 68Ga PET/CT images of patient-like phantoms reconstructed with different vendor-specific algorithms
  • PP25.13
  • Eposter presentation
The RATIONALE (RAdionuclide TheragnostIcs for persONALised mEdicine) cost action: State of the art and future prospective
  • PP25.15
  • Eposter presentation
Image reconstruction considerably effects DAT tracer distribution: A preliminary SPECT study in an anatomical brain phantom
  • PP29.03
  • Eposter presentation
Identification of side nuclear reactions as a source of neutron radiation during the production of the 11C isotope in the 14N(p,α)11C reaction
  • PP29.11
  • Eposter presentation
Radiation protection measures and monitoring of a patient with renal failure undergoing radioactive iodine I-131 therapy for thyroid cancer before and during hemodialysis
  • PP31.01
  • Eposter presentation
Quantitative evaluation method for planning and treatment dose distribution agreement in 90-Y radioembolization
  • PP31.02
  • Eposter presentation
Non-invasive blood and bone marrow dosimetry for I-131 treatment in patients with differentiated thyroid carcinoma: Tailored treatment
  • PP31.03
  • Eposter presentation
Developing a 3D printed paediatric pelvic phantom for use in nuclear medicine
  • PP31.04
  • Eposter presentation
Assessment of intrinsic performances of myocardial perfusion imaging systems in detecting perfusion defects
  • PP31.05
  • Eposter presentation
Image-based bone marrow dosimetry in patients undergoing [177Lu]Lu-PSMA radiopharmaceutical therapy
  • PP31.06
  • Eposter presentation
203/212Pb theranostic isotopes for targeted alpha therapy – SPECT imaging properties and first clinical experience
  • PP31.07
  • Eposter presentation
Impact of small patient motion during 177Lu-PSMA SPECT/CT scans onto lesion dosimetry based on a phantom simulation study
  • PP31.08
  • Eposter presentation
Count statistics optimization of myocardial perfusion imaging on a solid state detectors gamma camera: Preliminary results
  • PP31.09
  • Eposter presentation
Unlocking 3D virtual reality models for free using DICOM images: A preoperative planning tool
  • PP31.10
  • Eposter presentation
Needle adaption for robotic seed brachytherapy: A simulation study
  • PP31.12
  • Eposter presentation
Design and fabrication of a 3D-printed paediatric anthropomorphic pelvic kidney phantom for use in the nuclear medicine department
  • PP31.13
  • Eposter presentation
131I and 177Lu Voxel dosimetry: Operative aspects and clinical results
  • PP31.14
  • Eposter presentation
The relationship between activity administered and time of acquisition per bed position for 68Ga radiopharmaceuticals.
  • PP32.02
  • Eposter presentation
Urinary excretion rate of I-131 during treatment of benign thyroid disease
  • PP32.06
  • Eposter presentation
Assessment of occupational exposure during radioembolization procedure with Ho-166 microspheres
  • PP33.06
  • Eposter presentation
Yttrium-90 radioembolization: Assessing dose rates and radiation protection precautions
  • PP33.09
  • Eposter presentation
Investigation of the I-131 contamination risk after radioiodine therapy in patient rooms
  • PP33.11
  • Eposter presentation
Towards a more advanced approach to determine the external dose rates from nuclear medicine patients in close-contact scenarios
  • PS01.17
  • Eposter self-study
Machine learning-based survival prediction for newly diagnosed glioma patients using radiomic features extracted from MRI and PET images
  • PS02.18
  • Eposter self-study
Impact of the calibration curve on the calculation of dosimetric distributions and the DirectDensity algorithm
  • PS04.01
  • Eposter self-study
Developing local diagnostic reference levels for enhanced patient safety in adult PET/CT procedures at the Sultan Qaboos comprehensive cancer care and research center, Oman
  • PS04.02
  • Eposter self-study
Impact of background subtraction on the kidneys absorbed dose calculation in 177Lu-PSMA
  • PS04.03
  • Eposter self-study
Investigation on calibration coefficients of dose calibrators and their influence on different geometries for beta- and gamma-emitters
  • PS04.04
  • Eposter self-study
A Bayesian approach to automated quantification of myocardial perfusion imaging
  • PS04.05
  • Eposter self-study
Comparison of 3D printed radioactive spheres and fillable spheres for validation of threshold-based pet segmentation
  • PS04.06
  • Eposter self-study
Validation of radiomics in PET using 3D printed radioactive texture phantoms
  • PS04.08
  • Eposter self-study
Example of workflow for individual dosimetry in Peptide Receptor Radionuclide Therapy (PRRT) with Lu-177.
  • PS04.09
  • Eposter self-study
Repeatability of individual dosimetry results obtained by a single operator in a Peptide Receptor Radionuclide Therapy (PRRT) with Lu-177
  • PS04.10
  • Eposter self-study
Comparision and determination of local diagnostic reference levels for diagnostic procedures in nuclear medicine
  • PS04.11
  • Eposter self-study
Image fusion in PET/CT: A quick and easy check to enrich the system's QA
  • PS04.12
  • Eposter self-study
Use of a gamma probe in the preclinical assessment of tumor dosimetry in vivo for 177Lu-labeled PSMA-617
  • PS04.13
  • Eposter self-study
Retrospective comparison of the achieved treatment dose in radioiodine therapy depending on the pretherapeutic dosimetry
  • PS04.14
  • Eposter self-study
Blood vs vertebrae methods for bone marrow self absorbed dose estimation in 177Lu-PSMA therapy: A case study
  • PS04.15
  • Eposter self-study
Dosimetric comparison of the Simplicit90Y software in hepatic radioembolization with 90Y microspheres
  • PS04.16
  • Eposter self-study
Benchmarking of PET/CT doses in a digital PET/CT system against a new Irish national DRL
  • PS04.17
  • Eposter self-study
Calibration of the General Electric NM 870 DR gamma camera with the NEMA NU2-2007 phantom for clinical dosimetry on hepatic radioembolization with Y-90 microspheres
  • PS04.18
  • Eposter self-study
Calibration of the General Electric NM 870 DR gamma camera with the NEMA NU2-2007 phantom for dosimetry of metabolic treatments with I-131
  • PS09.02
  • Eposter self-study
Should medical physicists be involved in radiopharmaceutical regulations?
  • PS10.16
  • Eposter self-study
Activity in the saliva of rhTSH and THW thyroid cancer patients treated with Iodine-131